At least five candidates vie to become the next WHO leader, as questions over U.S. role loom
At least five candidates are in the running to become the next director-general of the WHO, a job that will come with…
Read at source →Source
STAT News
Medicine, biotech, and health policy
Health · 728 articles · page 8 of 21 · fetched 34 minutes ago
STAT+: The head of Kennedy’s new autism project has roots in Iraq War, Sesame Street
Advanced Research Projects Agency for Health is planning a total-lifespan research project on autism: A Q&A with its…
Read at source →
Opinion: RFK Jr.’s use of the National Center for Health Statistics will add confusion to measles deaths count
“A discrepancy between how federal and state public health officials determine measles deaths will only increase public…
Read at source →
AdSponsoredSiguimi
Pure chronological social — no algorithm
See who you follow, newest first. Free to join. Posts that stay visible — not buried by an algo.
Join siguimi.com →
Opinion: The ‘died with’ vs. ‘died of’ measles discussion misses something very important
“Arguing over whether someone died ‘with’ or ‘of’ a disease gets us stuck on the last thing that happened.” write two…
Read at source →
STAT+: FDA commissioner nominee Heidi Overton keeps opinions to herself in Senate hearing
Senators focused on asking Overton about vaccines, abortion, and vapes.
Read at source →
The FDA’s Overton era, and dispatches from Shanghai
The Readout LOUD is going international this week with a dispatch from Shanghai, along with notes on the FDA's Overton…
Read at source →
Senate finance committee backs Chris Klomp, advancing him to full Senate vote
Klomp, a behind-the-scenes HHS power player, is likely to be confirmed as second-in-command to RFK Jr.
Read at source →
STAT+: Indonesian ruling against ‘patent evergreening’ by pharma industry sends critical message, patient advocates say
A recent court decision in Indonesia sends an important message to other countries to challenge the pharma industry's…
Read at source →
STAT+: Kyverna’s cell therapy shows lasting autoimmune benefit
Kyverna Therapeutics is one step closer to launching the first cell therapy for an autoimmune disease, with new data in…
Read at source →
STAT+: Pharmalittle: We’re reading about the FDA commissioner nominee, a Lilly partnership in China, and more
During a Senate hearing today, Heidi Overton, the nominee to lead the FDA, plans to emphasize the need for speed and…
Read at source →
STAT+: The rise of the AI-native radiology practice
In this edition of STAT Health Tech: Radiology startups say owning a practice makes it easier to develop AI tools, and…
Read at source →
One of the most contagious diseases on the planet is having its worst U.S. outbreak since 1991
The CDC has added a single measles death to its online counter. In the last few weeks, four unvaccinated people have…
Read at source →
STAT+: Why Gilead can’t stop talking about its ambitions in immunology
Gilead Sciences’ top executives have been emphatically bullish about the biotech’s years-long push to develop drugs for…
Read at source →
STAT+: How a young doctor rose from rural New Mexico to FDA commissioner nominee
What to know about Dr. Heidi Overton, Trump's pick to run the FDA, including her medical background and career…
Read at source →
STAT+: In radiology, AI is blurring the line between technology development and clinical practice
A new wave of radiology practices are aggressively embracing AI: developing and deploying it in-house, and marketing…
Read at source →
STAT+: Momentum is building for a big change to how doctors get paid
Congress is considering linking doctor payment rates to medical inflation under the proposed Patients First Act.
Read at source →
STAT+: Trump boast on drug pricing policy overstated state-level interest in federal program
President Trump and his aides boasted that every U.S. state wanted to participate in a drug pricing initiative through…
Read at source →
STAT+: Heidi Overton, Trump’s pick for FDA head, faced questions at Senate hearing
Heidi Overton, Trump's pick for FDA head, will face questions at a Senate hearing. Follow along with our live blog.
Read at source →
Opinion: Measles almost killed me. Now I’m a doctor — and I’m scared of what’s happening
Jewel Mullen was in kindergarten in 1961 when she almost died from measles. Now a physician, measles’ return frightens…
Read at source →
Opinion: STAT+: A moment of reckoning for preventive cardiology and the precision medicine revolution
“The epidemiology and genetics of heart attack and stroke risk, for now, seem to have outpaced what more we can…
Read at source →
White House plan to increase control of NIH grants appears ‘dead’
A planned EO that would have greatly enhanced White House influence over grants at the NIH is “looking dead,” a source…
Read at source →
STAT+: Nominee to lead FDA aims to speed up medical research, combat China’s rise
Exclusive: Heidi Overton plans to tell senators she will speed up biomedical research, working with FDA staff.
Read at source →
STAT+: FDA advisory panel endorses Grail blood test for cancer, saying benefits outweigh risks
An FDA advisory panel has endorsed Galleri, a blood test designed by the biotech firm Grail to screen for multiple…
Read at source →
STAT+: Flagship gets a Pentagon contract
Biotech investment firm Flagship Pioneering has been awarded a contract by the Department of Defense to advance…
Read at source →
STAT+: AI doomerism: Here’s how to make sense of it
In this edition of STAT's AI Prognosis newsletter: Brittany Trang offers a few stories to make sense of the AI…
Read at source →STAT+: Pharmalittle: We’re reading about a closing loophole for importing meds, European competitiveness, and more
As of next month, a loophole that allows Americans to personally import their medications by mail is closing
Read at source →
The latest in the legal saga for youth gender-affirming care in the U.S.
The chilling effect of the Trump administration's dogged offensive against transgender health care has been swift, with…
Read at source →
STAT+: UnitedHealth, CVS push back on Medicare plan to curb remote patient monitoring
Some health insurers push back on a Medicare proposal that would disrupt how doctors can bill for remotely monitoring…
Read at source →
STAT+: Drugmakers, biotech VCs show ‘reinvigorated’ interest in osteoporosis treatments
Medicines for osteoporosis are grabbing the attention of the pharma industry, which has been incentivized by a…
Read at source →
Opinion: Mentally ill women deserve more support to have children
“The maternal mental health needs of women like me have been badly underprioritized in American society,” writes Meg…
Read at source →
STAT+: A private equity-owned hospital chain is becoming a nonprofit. Is it just a bailout for investors?
Other private equity-owned hospital chains have collapsed in recent years, so the stakes are high for Quorum.
Read at source →
STAT+: HHS unveils new initiatives to reduce animal testing in drug development
For the second time this year, HHS announced new strategies to speed the away from animals in medical testing.
Read at source →
Opinion: Former FDA commissioners: Heidi Overton has an opportunity to strengthen the FDA
Two former FDA commissioners: Heidi Overton is the right pick in a difficult moment.
Read at source →
STAT+: Did the Trump administration just cut Novo a huge financial win?
The White House's GENEROUS plan was designed to make drugs more affordable for Medicaid users. There's one glaring…
Read at source →
STAT+: Novo may be getting a better deal than expected with Medicare’s Bridge program
Eli Lilly and Novo Nordisk were already benefitting a great deal from the Trump administration's pilot program covering…
Read at source →
STAT+: Epic’s mortality model, and Omada’s future products
In this edition of STAT Health Tech: What Epic's mortality prediction algorithm tells us about AI in geriatrics,…
Read at source →